Dahlia Lithwick, who’s covering Wyeth v. Levine in the Supreme Court, describes the case like this:

“Wyeth is being called the most important business case of the year because, if the court finds that the FDA warning occupies the field of drug warnings, it will effectively immunize drug makers from many state tort suits. If it finds pre-emption here, the most business-friendly Supreme Court in decades can cancel the room with two queen-size beds and order a single king for itself and big pharma“.

The Knowledge Project, which is the National Coalition Against Censorship’s project to address censorship in science filed an amicus brief in August showing the 1st amendment ramifications to this case. In this article, Katherine A. Rabb, the Director of the Knowledge project, explains how this case hinges on the public’s ability to access information. You can read the whole article here.